AngioDynamics (ANGO) News Today $10.66 -0.23 (-2.11%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$10.72 +0.05 (+0.52%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Jane Street Group LLC Has $117,000 Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Jane Street Group LLC lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 68.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 12,749 shares of the medical instruments supplier's stock after selling 27,593 shares during theJune 8, 2025 | marketbeat.com42,258 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Purchased by Squarepoint Ops LLCSquarepoint Ops LLC acquired a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 42,258 shares of the medical instruments supplier's stock, valued at approximately $387,June 6, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Short Interest UpdateAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 1,850,000 shares, a growth of 24.2% from the April 30th total of 1,490,000 shares. Approximately 4.8% of the company's shares are short sold. Based on an average daily volume of 494,500 shares, the days-to-cover ratio is currently 3.7 days.June 3, 2025 | marketbeat.comMackenzie Financial Corp Has $589,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)Mackenzie Financial Corp grew its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 173.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 64,293 shares of the medical instruments supplier's stock aJune 3, 2025 | marketbeat.comTwo Sigma Investments LP Has $2.91 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Two Sigma Investments LP trimmed its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 9.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 317,856 shares of the medicaJune 1, 2025 | marketbeat.comTwo Sigma Advisers LP Reduces Position in AngioDynamics, Inc. (NASDAQ:ANGO)Two Sigma Advisers LP lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 31.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 260,700 shares of the medical instruments supplier's sMay 30, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Ameriprise Financial Inc. lifted its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 24.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 277,565 shares of the medical instrumeMay 30, 2025 | marketbeat.com185,245 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. bought a new stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 185,245 shares of the medical instruments supplieMay 28, 2025 | marketbeat.comNuveen Asset Management LLC Grows Position in AngioDynamics, Inc. (NASDAQ:ANGO)Nuveen Asset Management LLC increased its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 37.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,296,366 shares of the medical instruments supplier's sMay 28, 2025 | marketbeat.comBNP Paribas Financial Markets Cuts Position in AngioDynamics, Inc. (NASDAQ:ANGO)BNP Paribas Financial Markets lowered its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 62.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 60,021 shares of the medical insMay 26, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Position Trimmed by Millennium Management LLCMillennium Management LLC lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 3.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,162,568 shares oMay 23, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $2.26 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)D. E. Shaw & Co. Inc. increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 247,074 shares of the medical instruments supplier's stock after acquiring an adMay 23, 2025 | marketbeat.comParadigm Capital Management Inc. NY Takes Position in AngioDynamics, Inc. (NASDAQ:ANGO)Paradigm Capital Management Inc. NY bought a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 404,001 shares of the medical instruments supplierMay 22, 2025 | marketbeat.comSystematic Financial Management LP Has $23.09 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Systematic Financial Management LP boosted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 4.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,521,065 shares of the medical iMay 19, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires 107,829 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)Jacobs Levy Equity Management Inc. boosted its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 26.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 521,949 shares of the medical instruments supplier's stock after buying an addiMay 17, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Holdings Lifted by Balyasny Asset Management L.P.Balyasny Asset Management L.P. lifted its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 77.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 110,851 shares of the medical instruments supplier's stock after buying an additiMay 17, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Stake Reduced by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC reduced its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 46.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 135,350 shares of the medical instMay 16, 2025 | marketbeat.comBridgeway Capital Management LLC Has $324,000 Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Bridgeway Capital Management LLC trimmed its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 60.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,400 shares of the medical instruments supplier's stock after sMay 15, 2025 | marketbeat.comTudor Investment Corp ET AL Sells 115,929 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)Tudor Investment Corp ET AL lowered its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 85.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,838 shares of the medical instrumentMay 13, 2025 | marketbeat.comDimensional Fund Advisors LP Has $13.64 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO)Dimensional Fund Advisors LP increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,488,667 shares ofMay 11, 2025 | marketbeat.com514,635 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Purchased by Divisadero Street Capital Management LPDivisadero Street Capital Management LP acquired a new stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 514,635 shares of the medical instrumentMay 9, 2025 | marketbeat.comManatuck Hill Partners LLC Increases Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Manatuck Hill Partners LLC grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 166.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 199,500 shares of the medical instruments supplier's stockMay 4, 2025 | marketbeat.comAngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound?May 2, 2025 | msn.comZacks Research Expects Increased Earnings for AngioDynamicsAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities researchers at Zacks Research raised their FY2025 earnings estimates for shares of AngioDynamics in a report issued on Wednesday, April 23rd. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will poApril 27, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Marshall Wace LLPMarshall Wace LLP grew its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 1,335.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 476,824 shares of the medical instruments supplier's stockApril 27, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Holdings Lessened by Renaissance Technologies LLCRenaissance Technologies LLC reduced its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 913,029 shares of the medical instruments supplier's stock after sellingApril 20, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 254,322 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)JPMorgan Chase & Co. increased its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 807,483 shares of the medical instruments supplier's stock after acquiring an additional 2April 19, 2025 | marketbeat.comTrexquant Investment LP Reduces Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Trexquant Investment LP lessened its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 81,771 shares of the medical instruments supplier's stock afterApril 14, 2025 | marketbeat.comPrudential Financial Inc. Trims Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Prudential Financial Inc. lessened its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,366 shares of the medicaApril 13, 2025 | marketbeat.comHC Wainwright Lifts Earnings Estimates for AngioDynamicsAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Analysts at HC Wainwright lifted their FY2025 earnings per share estimates for AngioDynamics in a research note issued on Monday, April 7th. HC Wainwright analyst Y. Chen now expects that the medical instruments supplier will post earnings per shaApril 12, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Raises Stake in AngioDynamics, Inc. (NASDAQ:ANGO)Arrowstreet Capital Limited Partnership increased its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 293.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 352,544 shares of the medical instruApril 11, 2025 | marketbeat.comShareholders in AngioDynamics (NASDAQ:ANGO) are in the red if they invested three years agoApril 8, 2025 | finance.yahoo.comAngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPSAngioDynamics (NASDAQ:ANGO - Get Free Report) issued its quarterly earnings data on Wednesday. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year.April 5, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Updates FY25 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY25 earnings guidance. The company provided EPS guidance of ($0.34)-($0.31) for the period, compared to the consensus estimate of ($0.37). The company also issued revenue guidance of $285-288 millionillion, compared to the consensus estimate of $284.89 millionillion.April 4, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Releases FY 2025 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.340--0.310 for the period, compared to the consensus estimate of -0.370. The company also issued revenue guidance of $285.0 millionillion-$288.0 millionillion, compared to the consensus estimate of $284.9 millionillion.April 4, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Trims Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)Mitsubishi UFJ Asset Management Co. Ltd. trimmed its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 23.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 141,160 shares of the medical instruments supApril 4, 2025 | marketbeat.comAngioDynamics targets 14%-16% MedTech growth for fiscal 2025 driven by thrombectomy and NanoKnife adoptionApril 3, 2025 | msn.comAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call TranscriptApril 3, 2025 | insidermonkey.comStoneX Group Inc. Takes $981,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO)StoneX Group Inc. bought a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 107,083 shares of the medical instruments supplier's stock, valued at approximately $981,000. StoneX Group Inc. owned aApril 3, 2025 | marketbeat.comAngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...April 3, 2025 | gurufocus.comAngioDynamics reports Q3 adjusted EPS (8c), consensus (13c)April 3, 2025 | markets.businessinsider.comAngioDynamics up 13% in pre-market at $10.90 after Q3 results, guidance raiseApril 3, 2025 | markets.businessinsider.comQ3 2025 AngioDynamics Inc Earnings Call TranscriptApril 3, 2025 | gurufocus.comMedical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual GuidanceApril 2, 2025 | benzinga.comAngioDynamics to Host Virtual Cardiovascular Investor EventApril 2, 2025 | tipranks.comAngioDynamics 3Q Loss Narrows as Operating Expenses Slim DownApril 2, 2025 | marketwatch.comAngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsApril 2, 2025 | investing.comAngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsApril 2, 2025 | businesswire.comUncovering Potential: AngioDynamics's Earnings PreviewApril 1, 2025 | benzinga.comAngioDynamics to Host Virtual Cardiovascular Investor EventMarch 31, 2025 | finance.yahoo.com Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANGO Media Mentions By Week ANGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼0.440.90▲Average Medical News Sentiment ANGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼13▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alphatec News Today AtriCure News Today Integra LifeSciences News Today Orthofix Medical News Today Surmodics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
